The Efficacy and Clinical Safety of Various Analgesic Combinations for Post-Operative Pain after Third Molar Surgery: A Systematic Review and Meta-Analysis. by Leung, MYY et al.
Title
The Efficacy and Clinical Safety of Various Analgesic
Combinations for Post-Operative Pain after Third Molar Surgery:
A Systematic Review and Meta-Analysis.
Author(s) Au, AH; Choi, SW; Cheung, CW; Leung, MYY
Citation PLoS One, 2015, v. 10, p. e0127611
Issued Date 2015
URL http://hdl.handle.net/10722/211681
Rights Creative Commons: Attribution 3.0 Hong Kong License
RESEARCH ARTICLE
The Efficacy and Clinical Safety of Various
Analgesic Combinations for Post-Operative
Pain after Third Molar Surgery: A Systematic
Review and Meta-Analysis
Alvin Ho Yeung Au1, Siu Wai Choi2, Chi Wai Cheung2, Yiu Yan Leung1*
1 Oral and Maxillofacial Surgery, Faculty of Dentistry, The University of Hong Kong, Hong Kong Special
Administrative Region, People Republic of China, 2 Laboratory and Clinical Research Institute for Pain,
Department of Anaesthesiology, Faculty of Medicine, The University of Hong Kong, Hong Kong Special




To run a systematic review and meta-analysis of randomized clinical trials aiming to answer
the clinical question “which analgesic combination and dosage is potentially the most effec-
tive and safe for acute post-operative pain control after third molar surgery?”.
Materials and Methods
A systematic search of computer databases and journals was performed. The search and
the evaluations of articles were performed by 2 independent reviewers in 3 rounds. Ran-
domized clinical trials related to analgesic combinations for acute post-operative pain con-
trol after lower third molar surgery that matched the selection criteria were evaluated to
enter in the final review.
Results
Fourteen studies with 3521 subjects, with 10 groups (17 dosages) of analgesic combina-
tions were included in the final review. The analgesic efficacy were presented by the objec-
tive pain measurements including sum of pain intensity at 6 hours (SPID6) and total pain
relief at 6 hours (TOTPAR6). The SPID6 scores and TOTPAR6 scores of the reported an-
algesic combinations were ranged from 1.46 to 6.44 and 3.24 – 10.3, respectively. Ibupro-
fen 400mg with oxycodone HCL 5mg had superior efficacy (SPID6: 6.44, TOTPAR6:
9.31). Nausea was the most common adverse effect, with prevalence ranging from 0-55%.
Ibuprofen 200mg with caffeine 100mg or 200mg had a reasonable analgesic effect with
fewer side effects.
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Conclusion
This systematic review and meta-analysis may help clinicians in their choices of prescribing
an analgesic combination for acute post-operative pain control after lower third molar sur-
gery. It was found in this systematic review Ibuprofen 400mg combined with oxycodone
HCL 5mg has superior analgesic efficacy when compared to the other analgesic combina-
tions included in this study.
Introduction
The combination of analgesics from different classes may provide additive analgesic effects
with lesser side effects than when a single drug is used [1, 2]. It has also been suggested that the
combination of analgesics can provide different mechanisms of action and therefore multi-
modal coverage of a wider spectrum of pain, thus enable the drug components to provide po-
tential synergistic effect [3]. Moreover, in terms of safety, analgesic combinations may allow a
lower dose of single drug component, which may result in a lower incidence of adverse effects.
As multiple pathways of human body’s nociception were suggested [4], analgesic combinations
are appropriate for pain management and has been recommended by World Health Organiza-
tion (WHO) [5], the American Pain Society (APS) [6] and the American College of Rheuma-
tology (ACR) [7].
Acute post-operative dental pain model has been suggested as an excellent analgesic model
because the pain can be debilitating [8]. Wisdom tooth surgery has been commonly used in
studies to investigate the efficacy of single or combination analgesics [9–11]. Review of the lit-
erature demonstrated that analgesic combinations of NSAIDs or acetaminophen and opioids
were superior to single drug in terms of analgesic effect and/ or side-effect for acute post-opera-
tive pain [12].
However, among the enormous number of possible combinations, there is a lack of knowl-
edge regarding which therapeutic analgesic combination and the respective drug dosages is
more superior in terms of analgesic efficacy and its clinical safety. Therefore the purpose of the
study was to conduct a systematic review and meta-analysis to answer a clinical question
“which analgesic combination and dosage is potentially the most effective and safe for acute
post-operative pain control after third molar surgery?”
Materials and Methods
A systematic review and meta-analysis was designed to perform two rounds of comprehensive
searches of literature with relevance to the clinical question and a round of critical evaluation
to identify relevant articles that could be included in the final review. Two authors (A.H.Y. and
L.Y.Y.) were judges in the two rounds of search and the evaluation round, and worked inde-
pendently according to the protocol and were blinded to each other’s choice. Disagreements
between two judges were discussed and solved by consent. A third party (N.S.) was consulted if
any consensus to a disagreement could not be reached.
First round search
Three databases (Pubmed, Embase and the Cochrane Library) were searched. There were no
restriction criteria set on language or publication date. The last date of the search was 1st
March, 2013. The electronic search was performed using the keywords:
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6. acute dental pain
7. combination
A search was performed by (1 or 2 or 3) AND (4 or 5 or 6 or 7)
A list of articles with the search strategy was generated. Each abstract of the articles was re-
viewed. The full articles were retrieved if there was inadequate information in the abstracts or
the abstracts were missing. Articles relevant to the study of analgesics combination and third
molar surgery were selected and included in the next round.
Second round search and selection
To expand the search for possible articles that were relevant to the topic, a manual search was per-
formed on three international oral and maxillofacial surgery journals (Oral Surgery, Oral Medi-
cine, Oral Pathology, Oral Radiology, and Endodontology; International Journal of Oral and
Maxillofacial Surgery; and Journal of Oral andMaxillofacial Surgery). The manual search of these
3 journals was limited to the period fromMarch 2003 to Feb 2013. Articles relevant to the treat-
ment of post-operative dental pain and uses of combination analgesia were selected in this round.
A reference list search was performed from the manual search articles and the selected arti-
cles of the first round articles. Articles that were relevant to the study of post-operative dental
pain and combination of analgesic efficacy and clinical safety were selected.
In addition to the articles from the first round, all articles were evaluated. Two independent
judges (A.H.Y and L.Y.Y) carried out independent selection of the articles entered this round,
according to the following selection criteria:
1. Articles must be limited to third molar surgery;
2. Articles must be limited for assessing the combination of analgesic;
3. Articles must be randomized clinical trials.
Articles had to fulfill all these three criteria to be selected to enter the third
round evaluation.
Third round evaluation
Articles entering the third round were evaluated by two independent judges (A.H.Y and L.Y.Y)
based on the following criteria.
1. The study must contain one or more of the following information about the patients who
underwent wisdom tooth surgery: basic demographic data (mean age, gender of patients);
number of wisdom teeth removed; and baseline pain intensity.
2. The study must contain a placebo group.
3. The articles must consist of the following two objective pain measurements that were com-
monly used in analgesic studies:
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• Sum of pain intensity difference in 6 hours (SPID6);
• Total pain relief in 6 hours (TOTPAR6).
4. The articles must include the adequate description on the side effect, patient tolerability and
safety of the drugs.
Articles had to fulfill all criteria to be included in the final review. Table 1 summarized the
eligibility criteria for articles included in the final review. Table 2 listed the excluded studies
and the reasons for exclusion.
Final review
Articles entering the final review were being assessed of the efficacies and the adverse effects of
the analgesic combinations reported in the studies. Drug efficacy was reported by the two ob-
jective pain measurements, SPID6 and TOTPAR6 (SeeObjective pain measurements). Single
drug analgesics reported in the included studies were not assessed. The reported SPID6 and
TOTPAR6 value of the placebos in the included articles reported and compared with the anal-
gesic combinations. When there were multiple studies reporting the same analgesic combina-
tion and same dosage, the mean SPID6 and mean TOTPAR6 of the analgesic combination and
the respective placebo was calculated according to the formula:
MeanSPID6=TOTPAR6of ananalgesiccombinationorplacebo
¼ ½ðSPID6orTOTPAR6instudyAÞ  ðnumberof subjectsof studyAÞ
þ ðSPID6orTOTPAR6instudyBÞ  ðnumberof subjectsof studyBÞ þ . . .
þ ðSPID6orTOTPAR6instudyXÞ
 ðnumberof subjectsof studyXÞ=Totalnumberof subjects inthestudies:
The adjusted effect of an analgesic combination reported in each included study was calcu-
lated by offsetting the placebo effect within the same study to report its actual effect. The for-
mulae to calculate the adjusted SPID6 and TOTPAR6 were as follows:
1. Adjusted SPID6 = SPID6 of drug—SPID6 of placebo
2. Adjusted TOTPAR6 = TOTPAR6 of drug—TOTPAR6 of placebo
The adverse effects of the analgesic combinations of the included studies were reported. The
proportion of subjects complaining of an adverse effect of the analgesic combination were re-
ported and compared. When there were multiple studies reporting the same analgesic
Table 1. Eligibility criteria for articles included in the final review.
Type of studies: Randomized control trial with a minimal sample size of 15 patients and placebo.
Type of participants: Patients had surgical extraction of 1 or more third molar which was partial or complete
bony impacted mandibular third molar; experience moderate or severe pain associated with the procedure.
Type of intervention: For the acute post-operative pain control, patients received any combination
analgesia, the type of drugs combination and the route and the dosage of therapy must be clearly reported.
Type of outcome measures:
Primary outcome
• Sum of Pain Intensity at 6 hours (SPID6)Total pain relief at 6 hours (TOTPAR6)
Secondary outcome
• To report different drug combination adverse effect
The method, criteria and time of evaluation must be clearly reported. The analgesic efﬁciency outcomes
speciﬁc for SPID6 and TOTPAR6 needs to be reported.
doi:10.1371/journal.pone.0127611.t001
Analgesic Combination Meta-Analysis
PLOS ONE | DOI:10.1371/journal.pone.0127611 June 8, 2015 4 / 25
Table 2. Excluded studies at the third round and explanation for exclusion.
Authors Title Reasons for exclusion
1. Sveen K, et al [71]. Paracetamol/codeine in relieving pain following removal of impacted
mandibular third molars.
No SPID6 and TOTPAR6 data
2. Hellem S, et al [72]. A model for evaluating the analgesic effect of a new ﬁxed ratio combination
analgesic in patients undergoing oral surgery.
No SPID6 and TOTPAR6 data
3. Forbes JA, et al
[73].
An evaluation of the analgesic efﬁcacy of three opioid-analgesic
combinations in postoperative oral surgery pain.
No SPID6 and TOTPAR6 data
4. Quiding H, et al
[74].
An analgesic study with repeated doses of phenazone, phenazone plus
dextropropoxyphene, and paracetamol, using a visual analogue scale.
No SPID6 and TOTPAR6 data No placebo
5. Quiding H, et al
[75].





Analgesia following oral surgery: a comparative study of Solpadeine and a
soluble form of dextropropoxyphene napsylate and paracetamol.
No SPID6 and TOTPAR6 dataNo placebo
7. Laska EM, et al
[77].
Effect of caffeine on acetaminophen analgesia. No placebo
8. Dionne RA, et al
[78].
Comparison of conorphone, a mixed agonist-antagonist analgesic, to
codeine for postoperative dental pain.
No placebo
9. Ahlstrom U, et al
[79].
Multiple doses of paracetamol plus codeine taken immediately after oral
surgery.
No SPID6 and TOTPAR6 data
10. Dahl E, et al [80]. Acetylsalicylic acid compared with acetylsalicylic acid plus codeine as
postoperative analgesics after removal of impacted mandibular third
molars.
No placebo
11. Rosen M, et al
[81].
Suprofen compared to dextropropoxyphene hydrochloride and paracetamol
(Cosalgesic) after extraction of wisdom teeth under general anaesthesia.
No placebo
12. Frame JW, et al
[82].
A double-blind placebo-controlled comparison of three ibuprofen/codeine
combinations and aspirin.
No SPID6 and TOTPAR6 data
13. Happonen RP,
et al [83].
A combination of acetylsalicylic acid and codeine phosphate versus
acetylsalicylic acid as postoperative analgesics after mandibular third molar
surgery.
No SPID6 and TOTPAR6 data
14. Hill CM, et al [84]. Ibuprofen given pre- and post-operatively for the relief of pain. No SPID6 and TOTPAR6 data
15. Liashek P, et al
[85].
Effect of pretreatment with acetaminophen-propoxyphene for oral surgery
pain.
No SPID6 and TOTPAR6 data
16. Sagne S, et al
[86].
Analgesic efﬁcacy and side-effect proﬁle of paracetamol/codeine and
paracetamol/dextropropoxyphene after surgical removal of a lower wisdom
tooth.
No placebo
17. Dupuis R, et al
[87].
Preoperative Flurbiprofen in Oral Surgery: A Method of Choice in
Controlling Postoperative Pain.
No SPID6 and TOTPAR6 data
18. McQuay HJ, et al
[88].
Codeine 20 mg increases pain relief from ibuprofen 400 mg after third
molar surgery. A repeat-dosing comparison of ibuprofen and an ibuprofen-
codeine combination.
No placebo
19. Becker J, et al
[89].
Double blind biometric study on postoperative effects of analgesics. No placebo
20. Giglio JA, et al
[90].
Double-blind comparison of meclofenamate sodium plus codeine,
meclofenamate sodium, codeine, and placebo for relief of pain following
surgical removal of third molars.
No SPID6 and TOTPAR6 data
21. Habib S JA, et al
[91].
A study of the comparative efﬁcacy of four common analgesics in the
control of postsurgical dental pain.
No placebo
22. Walton GM, Rood
JP [92].
A comparison of ibuprofen and ibuprofen-codeine combination in the relief
of post-operative oral surgery pain.
No placebo
23. Skoglund LA JA,
et al [93].
Analgesic efﬁcacy of acetaminophen 1000 mg, acetaminophen 2000 mg,
and the combination of acetaminophen 1000 mg and codeine phosphate 60
mg versus placebo in acute postoperative pain.
No SPID6 and TOTPAR6 data
24. Hellman M JA,
et al [94].
Analgesic efﬁcacy of an ibuprofen-codeine combination in patients with
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Table 2. (Continued)
Authors Title Reasons for exclusion
25. Lownie JF JA,
et al [95].
Comparison of the safety and efﬁcacy of a combination analgesic Myprodol
and Ponstan in the treatment of dental pain.
No placebo
26. Lysell L JA, et al
[96].
Pain control after third molar surgery–a comparative study of ibuprofen
(Ibumetin) and a paracetamol/codeine combination (Citodon).
No placebo
27. McQuay HJ JA,
et al [97].
A multiple dose comparison of combinations of ibuprofen and codeine and
paracetamol, codeine and caffeine after third molar surgery.
No placebo
28. Dolci G JA, et al
[98].
Analgesic efﬁcacy and the tolerance for piroxicam-beta-cyclodextrin
compared to piroxicam, paracetamol and placebo in the treatment of
postextraction dental pain.
No SPID6 and TOTPAR6 data
29. Petersen JK JA,
et al [99].
The effect of an ibuprofen-codeine combination for the treatment of patients
with pain after removal of lower third molars.
No placebo
30. Dionne RA, et al
[100].
Analgesic efﬁcacy of ﬂurbiprofen in comparison with acetaminophen,
acetaminophen plus codeine, and placebo after impacted third molar
removal.
No SPID6 and TOTPAR6 data
31. Berge TI [101]. Pattern of self-administered paracetamol and codeine analgesic
consumption after mandibular third-molar surgery.
No placebo
32. McGurk M, et al
[102].
Clinical comparison of dexketoprofen trometamol, ketoprofen, and placebo
in postoperative dental pain.
No SPID6 and TOTPAR6 data
33. Merry AF, et al
[103].
Tenoxicam and paracetamol-codeine combination after oral surgery: a
prospective, randomized, double-blind, placebo-controlled study.
No SPID6 and TOTPAR6 data
34. Breivik EK, et al
[104].
Combining diclofenac with acetaminophen or acetaminophen-codeine after
oral surgery: a randomized, double-blind single-dose study.
No placebo
35. Dionne RA, et al
[105].
Additive analgesic effects of oxycodone and ibuprofen in the oral surgery
model.
No placebo
36. Caruso FS, et al
[106].
MorphiDex pharmacokinetic studies and single-dose analgesic efﬁcacy
studies in patients with postoperative pain.
No SPID6 and TOTPAR6 data
37. Ziccardi VB, et al
[107].
Single-dose vicoprofen compared with acetaminophen with codeine and
placebo in patients with acute postoperative pain after third molar
extractions.
No SPID6 and TOTPAR6 data
38. Medve RA, et al
[108].
Tramadol and acetaminophen tablets for dental pain. No SPID6 and TOTPAR6 data
39. Comfort MB, et al
[109].
A study of the comparative efﬁcacy of three common analgesics in the
control of pain after third molar surgery under local anaesthesia.
No placebo
40. Daniels SE, et al
[110].
The analgesic efﬁcacy of valdecoxib vs. oxycodone/acetaminophen after
oral surgery.
No SPID6 and TOTPAR6 data
41. Fricke JR, et al
[111].
A double-blind, single-dose comparison of the analgesic efﬁcacy of
tramadol/acetaminophen combination tablets, hydrocodone/acetaminophen
combination tablets, and placebo after oral surgery.
No SPID6 and TOTPAR6 data
42. Garibaldi JA, et al
[112].
Evaluation of ketorolac (Toradol) with varying amounts of codeine for
postoperative extraction pain control.
No placebo
43. James Fricke TV,
et al [113].
Rofecoxib compared to oxycodone/acetaminophen for post-operative
dental pain.
2004 Merck & co voluntary worldwide withdrawal
rofecoxib from the market due to risks of MI,
Stroke, CVD
44. Kiersch TA, et al
[114].
The onset of action and the analgesic efﬁcacy of Saridon (a
propyphenazone/paracetamol/ caffeine combination) in comparison with
paracetamol, ibuprofen, aspirin and placebo (pooled statistical analysis).
No SPID6 and TOTPAR6 data
45. Macleod AG, et al
[115].
Paracetamol Versus Paracetamol-Codeine in the Treatment of Post-
Operative Dental Pain: A Randomized, Double-Blind, Prospective Trial.
No placebo
46. Joshi A, et al
[116].
A double-blind randomised controlled clinical trial of the effect of
preoperative ibuprofen, diclofenac, paracetamol with codeine and placebo
tablets for relief of postoperative pain after removal of impacted third
molars.
No SPID6 and TOTPAR6 data
(Continued)
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combination of the same dosage, the mean proportion of subjects presenting with the adverse
effect were reported.
Objective pain measurements
1. Sum of pain intensity difference in 6 hours (SPID6). SPID6 measured the difference of
the sum of pain intensity score in the first 6 hours post-operatively. Pain intensity score
was reported subjectively by the subject on a four-point scale (0 = none; 1 = slight; 2 =mod-
erate; 3 = severe). The baseline pain intensity score was recorded after third molar surgery
and local anaesthesic effect was subsided. Analgesics were administered afterwards.
The Pain Intensity Difference (PID) was measured by the pain intensity score at baseline
minus the pain intensity score at a given observation time point, which was recorded hourly in
the first 6 hours. The sum of Pain Intensity Difference (SPID) for the 0 to 6-hour observation
period was reported as SPID6. The higher score represents more effective analgesia.
2. Total pain relief in 6 hours (TOTPAR6). Pain relief was measured by a categorical rating
scale (0 = none; 1 = slight; 2 = moderate; 3 = good; 4 = complete). Pain relief after
Table 2. (Continued)
Authors Title Reasons for exclusion
47. Jung YS, et al
[117].
Onset of analgesia and analgesic efﬁcacy of tramadol/acetaminophen and
codeine/acetaminophen/ibuprofen in acute postoperative pain: a single-
center, single-dose, randomized, active-controlled, parallel-group study in a
dental surgery pain model.
No SPID6 and TOTPAR6 result not available
48. Korn S, et al [118]. Comparison of rofecoxib and oxycodone plus acetaminophen in the
treatment of acute pain: a randomized, double-blind, placebo-controlled
study in patients with moderate to severe postoperative pain in the third
molar extraction model.
2004 Merck & co voluntary worldwide withdrawal
rofecoxib from the market due to risks of MI,
Stroke, CVD
49. Chang DJ, et al
[119].
Analgesic efﬁcacy of rofecoxib compared with codeine/acetaminophen
using a model of acute dental pain.
2004 Merck & co voluntary worldwide withdrawal
rofecoxib from the market due to risks of MI,
Stroke, CVD
50. Barroso AB, et al
[120].
Efﬁcacy and safety of combined piroxicam, dexamethasone, orphenadrine,
and cyanocobalamin treatment in mandibular molar surgery.
No placebo
51. Haglund B, et al
[121].
Combining paracetamol with a selective cyclooxygenase-2 inhibitor for
acute pain relief after third molar surgery: a randomized, double-blind,
placebo-controlled study.
No SPID6 and TOTPAR6 data
52. Desjardins PJ,
et al [122].
A double-blind randomized controlled trial of rofecoxib and multidose
oxycodone/acetaminophen in dental impaction pain.
2004 Merck & co voluntary worldwide withdrawal
rofecoxib from the market due to risks of MI,
Stroke, CVD
53. Leone M, et al
[123].
Comparison of methylprednisolone and ketoprofen after multiple third molar
extraction: a randomized controlled study.
No placebo
54. Borel JF, et al
[124].
Treating pain after dental surgery: a randomised, controlled, double-blind
trial to assess a new formulation of paracetamol, opium powder and
caffeine versus tramadol or placebo.
No SPID6 and TOTPAR6 data
55. Merry A, et al
[125].
Combined acetaminophen and ibuprofen for pain relief after oral surgery in
adults: a randomized controlled trial.
No SPID6 and TOTPAR6 data No placebo
56. Daniels SE, et al
[126].
Evaluation of the dose range of etoricoxib in an acute pain setting using the
postoperative dental pain model.
No SPID6 and TOTPAR6 data
57. Isiordia- Espinoza
MA, et al [127].
Preemptive analgesic effectiveness of oral ketorolac plus local tramadol
after impacted mandibular third molar surgery.
No SPID6 and TOTPAR6 data No placebo
58. Brown JD, et al
[128].
Evaluation of Multiday Analgesia With Etoricoxib in a Double-blind,
Randomized Controlled Trial Using the Postoperative Third-molar
Extraction Dental Pain Model.
No SPID6 and TOTPAR6 data
doi:10.1371/journal.pone.0127611.t002
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analgesic consumption was recorded at different post-operative time points, which was
recorded hourly in the first 6 hours. The summation of pain relief score on each hour in
the first 6 hours resulted in TOTPAR 6. It was defined as the area under the curve of the
pain relief scores against the corresponding time interval. For example if a patient had
complete pain relief immediately after taken the analgesic, and sustained it for the full 6
hours of observation period, the maximum TOTPAR6 would be (6 hours x 4) 24. The
higher the score represented the analgesic was more effective.
Data Synthesis
Meta-analysis of the data was performed by first looking at the heterogeneity of the studies in-
cluded in this paper. Cochrane Q and quantification of dispersion between studies using I2, val-
ues were calculated using Comprehensive Meta-Analysis (version 2.2.064, Englewood, New
Jersey). The random effects model was chosen and significance level was set at 0.05.
The manuscript was based on a master thesis of the first author, which was submitted in
September 2013 to the University of Hong Kong. The meta-analysis of the study was per-
formed by the second author. A re-search was performed in September 2014 using the key-
words and found no new studies to be included. The authors therefore prefer to use the
original search date for the systematic review and meta-analysis.
Results
A flow diagram of the three rounds of search and evaluation was presented in Fig 1. The first
round search of the computer base, covering the period from the earliest available date to 1st
March 2013, yielded 896 hits from PubMed, 137 hits fromMedline and 82 hits from the
Cochrane Library. One hundred and eighty three hits were duplications and were removed.
The abstracts of 932 articles were screened, 365 articles were considered relevant to the study
of the efficacy and clinical safety of analgesic combination of post-operative acute dental pain,
with 567 articles were considered irrelevant and were excluded. The second round search
yielded 4 additional articles from manual search and 4 additional articles from reference
search. After selection, 71 articles met the three criteria and entered the third round for evalua-
tion. Fifty-eight studies failed to meet one or more of the criteria in the evaluation round and
were excluded. Fourteen studies fulfilled the eligibility criteria and entered the final review.
General findings
The 14 included studies [13–25] of the final review were all randomized clinical trial with place-
bo control. These articles were published between 1986 and 2012. Two were multi-center stud-
ies [21, 25], thirteen were double blinded single oral dose studies [13, 14, 16–25] and one study
was double blinded with repeated doses [15]. All studies reported the basic demographic data.
There were a total of 3521 subjects included the 14 included studies. Of these, 1748 subjects
received different combinations and dosages of analgesics and 629 subjects received placebo.
The remaining 1144 subjects of these studies had single drug analgesics and were excluded
from the review.
Ten groups of drug combinations were identified in the final review according to the type of
drug combined. They were 1) acetaminophen + codeine phosphate; 2) acetaminophen + hydroco-
done bitartrate; 3) acetaminophen + oxycodone HCL; 4) acetaminophen + ibuprofen 5) aspirin
+ caffeine; 6) aspirin + codeine phosphate; 7) aspirin + caffeine + butalbital + codeine phosphate;
8) ibuprofen + oxycodone HCL; and 9) ibuprofen + caffeine; 10) ibuprofen + codeine phosphate
Analgesic Combination Meta-Analysis
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Fig 1. Flow diagram for article selection.
doi:10.1371/journal.pone.0127611.g001
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There were 17 drug combinations with different dosages and were listed below.
1. Acetaminophen 650mg + codeine phosphate 60mg
2. Acetaminophen 600mg + codeine phosphate 60mg
3. Acetaminophen 300mg + codeine phosphate 30mg
4. Acetaminophen 1g + codeine phosphate 30mg
5. Acetaminophen 1g + hydrocodone bitartrate 10mg
6. Acetaminophen 500mg + hydrocodone bitartrate 7.5mg
7. Acetaminophen 325mg + oxycodone HCL 5mg
8. Acetaminophen 500mg + ibuprofen 200mg
9. Acetaminophen 1g + ibuprofen 400mg
10. Aspirin 650mg + caffeine 65mg
11. Aspirin 650mg + codeine phosphate 60mg
12. Aspirin 325mg + caffeine 40mg + butalbital 50mg + codeine phosphate 15mg
13. Ibuprofen 400mg + oxycodone HCL 5mg
14. Ibuprofen 200mg + caffeine 200mg
15. Ibuprofen 200mg + caffeine 100mg
16. Ibuprofen 200mg + caffeine 50mg
17. Ibuprofen 400mg + codeine phosphate 25.6mg
Efficacy of analgesic combinations
The efficacies of the analgesic combinations in terms of SPID6 and TOTPAR6 were reported
in Table 3.
Seven of the 17 different analgesic combinations with different dosages described in the in-
cluded studies involved acetaminophen combining with an opioid (codeine phosphate, hydroco-
done bitartrate or oxycodone HCL), with the adjusted SPID6 and adjusted TOTPAR6 of ranged
from 1.46–3.7 and 3.24–7.2 respectively. Four of these combinations involved different dosages of
acetaminophen combined with codeine phosphate. There was no obvious difference of efficacy in
terms of SPID6 and TOTPAR6 between acetaminophen 650mg + codeine phosphate 60mg and
acetaminophen 600mg + codeine phosphate 60mg. But these two combinations were more effec-
tive than acetaminophen 300mg + codeine phosphate 30mg, with adjusted SPID6 and adjusted
TOTPAR6 at least 2.1 and 1.6 times higher, respectively, than the lower dosage combination.
Three of the analgesic combinations from the included studies involved aspirin as a major
analgesic component, with the adjusted SPID6 and adjusted TOTPAR6 were ranged from 1.8–
3.09 and 4.4–6.7, respectively. The four drugs combination of aspirin 325mg+caffeine 40mg
+ butalbital 50mg + codeine phosphate 15mg showed the highest efficacy in terms of adjusted
SPID6 (3.09) and TOTPAR6 (6.7) among the three, followed by aspirin 650mg + caffeine
65mg and aspirin 650mg + codeine phosphate 60mg.
Seven of the analgesic combinations reported in the included studies had ibuprofen as a
major analgesic component, with the adjusted SPID6 and adjusted TOTPAR6 were ranged
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Table 3. Summary of efficacy of various analgesic combinations of the included studies.








Acetaminophen 650mg + codeine phosphate 60mg Sunshine [24]
(n = 31)
4.66 (1.65) 3.01 13.37 (8.3) 5.07





3.48 (0.25) 8.19 (2.91)
Forbes [16]
(n = 17)
4.65 (0.13) 10.53 (2.00)
Calculated Mean 4.48 (0.84) 3.64 10.28 (4.08) 6.20
Acetaminophen 300mg + codeine phosphate 30mg Forbes [73]
(n = 93)
2.78 (0.51) 6.61 (3.35)
Forbes [73]
(n = 43)
3.12 (0.37) 7.44 (2.37)
Gatoulis [20]
(n = 119)
4.14 (3.79) 6.09 (3.54)
Calculated Mean 3.47 (2.01) 1.46 6.51 (3.27) 3.24
Acetaminophen 1g + codeine phosphate 30mg Daniels [129]
(n = 113)
1.00 (0.14) 0.86 1.87 (0.44) 1.43
Acetaminophen 1g + hydrocodone bitartrate 10mg Fricke [19] (n = 65) 3.7 (0) 3.70 10.3 (3.1) 7.20
Acetaminophen 500mg + hydrocodone bitartrate 7.5mg Forbes [14]
(n = 94)
3.57 (0.51) 8.66 (3.35)
Litkowski [21]
(n = 62)
3.32 (0.69) 8.36 (5.05)
Calculated Mean 3.47 (0.58) 2.89 8.54 (4.03) 4.51
Acetaminophen 325mg + oxycodone HCL 5mg Litkowski [21]
(n = 62)
3.58 (0.69) 2.89 9.53 (5.05) 4.48
Acetaminophen 500mg + ibuprofen 200mg Daniels [129]
(n = 173)
1.30 (0.14) 1.16 2.36 (0.44) 1.92
Acetaminophen 1g + ibuprofen 400mg Daniels [129]
(n = 168)
1.47 (0.14) 1.33 2.58 (0.44) 2.14
Aspirin 650mg + caffeine 65mg Forbes [17]
(n = 66)
2.88 (0.12) 2.76 6.8 (1.99) 4.81
Aspirin 650mg + codeine phosphate 60mg Moore [23] (n = 38) 2.2 (0.4) 1.80 6.9 (2.5) 4.40
Aspirin 325mg+caffeine 40mg + butalbital 50mg
+ codeine phosphate 15mg
Forbes [18]
(n = 41)
3.46 (0.37) 3.09 9.07 (2.37) 6.70
Ibuprofen 400mg + oxycodone HCL 5mg Litkowski [21]
(n = 62)
7.78 (0.69) 14.98 (5.05)
Van Dyke [25]
(n = 186)
6.54 (0.32) 13.3 (4.2)
Calculated Mean 6.85 (0.41) 6.44 13.72 (4.41) 9.31
Ibuprofen 200mg + caffeine 200mg McQuay [97]
(n = 29)
3.5 (0) 3.50 9.5 (0) 9.50
Ibuprofen 200mg + caffeine 100mg McQuay [97]
(n = 30)
3.1 (0) 3.10 10.3 (0) 10.30
Ibuprofen 200mg + caffeine 50mg McQuay [97]
(n = 30)
1.5 (0) 1.50 7.0 (0) 7.00
Ibuprofen 400mg + codeine phosphate 25.6mg Daniels [129]
(n = 169)
1.23 (0.14) 1.09 2.23 (0.44) 1.79
doi:10.1371/journal.pone.0127611.t003
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from 1.5–6.44 and 7.0–10.3, respectively. Ibuprofen 400mg + oxycodone HCL 5mg showed the
highest adjusted SPID6 then the other three combinations of ibuprofen with caffeine in differ-
ent dosages, which was at least 1.84 times better in adjusted SPID6. For the analgesic combina-
tions of ibuprofen with caffeine, it seemed that the analgesic efficacy did not drastically
increase when the dosage of caffeine was increase from 100mg to 200mg, which was interpreted
by similar adjusted SPID6 and TOTPAR6 findings. However, ibuprofen 200mg + caffeine
50mg was obviously less effective when compared to the two combinations of ibuprofen
200mg and caffeine in higher dosages.
Among the 17 different analgesic combinations reported in the included studies, ibuprofen
400mg + oxycodone HCL 5mg had the highest adjusted SPID6 (6.44), and a very higher adjust-
ed TOTPAR6 (9.31), representing its efficacy could be the superior than the other different an-
algesic combinations reported in this study.
Meta-analysis and Forest plots
Studies were analyzed separately both according to the SPID6, and then according to the TOT-
PAR6 scores obtained. The observed between study dispersion, (Cochrane Q value) calculated
according to SPID6 and TOTPAR were both p<0.0001, with 17 degrees of freedom (18 studies
being included in this analysis) which shows homogenous treatment according to the random
effects model. The I2 value calculated according to SPID6 and TOTPAR was both 0.0%, which
represents less than moderate heterogeneity. Forest plots were presented according to either
SPID6, or TOTPAR (Figs 2 and 3). Both figures confirmed all analgesic combinations were bet-
ter than the placebo, and showed Ibuprofen 400mg with oxycodone 5mg offered the highest
analgesic effect after lower third molar surgery.
Safety of analgesic combinations
The summary of the adverse effects of the various analgesic combinations from the included
studies was listed in Table 4. The common adverse effects were mostly related to the side effects
of opioids, including drowsiness, dizziness, headache and nausea. Nausea was the most com-
mon adverse effect in opioids containing combinations, ranging from 2.4% to 55%. Other rarer
adverse effects (e.g. leg numbness, chills, itchy, dry mouth, sweating) were also reported in
most of the analgesic combinations but in general the prevalence was low.
Among the 7 combinations of acetaminophen and an opioids (codeine phosphate, hydroco-
done bitartrate or oxycodone HCL), it was noted acetaminophen 1g + hydrocodone bitartrate
10mg had the highest incidence of adverse effects, with 55% of the subjects complaining of nau-
sea or vomiting, 22.4% of the subjects with dizziness, 15% with headache and 10.5% with
drowsiness. Acetaminophen 500mg + hydrocodone bitartrate 7.5mg was reported to have
fewer subjects with adverse effect, which was likely to be related to the reduced dosage of
hydrocodone bitartrate, with only 15.25% of the subjects experienced nausea and 8.47% with
drowsiness. There were also 41% of the subjects who took the combination of acetaminophen
325mg and oxycodone HCL 5mg experienced nausea. The combinations of acetaminophen
and codeine phosphate had fewer adverse effects reported when compared to the combinations
of acetaminophen and hydrocodone bitartrate or oxycodone HCL. From the included studies,
it seemed that reduced dosages of acetaminophen and codeine phosphate did not result in a re-
duced incidence of the side effects of the opioids.
The adverse effects of the two studies reported the use of ibuprofen 400mg + oxycodone
HCL 5mg were pooled. The prevalence of the subjects who experienced drowsiness was
13.25%. The other adverse effects were related to the side effect of the opioid oxycodone HCL
but the prevalences were low (0.4–2.4%).
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In contrast to the analgesic combinations containing opioids, combinations of an NSAID
with caffeine were reported to have much fewer adverse effects. In the same study reporting
combinations of ibuprofen 200mg and 3 different dosages of caffeine, there seemed to have no
obvious difference in terms of prevalence of adverse effect with the increased dosage (up to caf-
feine 200mg).
Discussion
Systematic reviews and meta-analyses have become increasingly popular in medicine [26, 27].
It helps clinicians to keep up-to-date clinical practice guideline and facilitate researchers to use
them as a starting point for new guideline formation and future research [28, 29]. It can also
provide a high-level overview of a particular research or clinical question by the process of
identify, select, synthesize and appraise all high quality research evidence [30]. According to
the oxford levels of evidence, systematic review of randomized controlled trials (RCT) is con-
siderate to be level 1 evidence [27]. This study tried to summarize objectively the efficacy and
clinical safety of various analgesic combination of post-operative acute dental pain. There were
Fig 2. Forest plot according to SPID6.
doi:10.1371/journal.pone.0127611.g002
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only randomized controlled trials (RCT) with placebo were selected into the final round for
analysis, the protocol was straightly followed the PRISMA statement (Preferred Reporting
Items for Systematic reviews and Meta-Analyses) [31] and it helps to ensure the clarity and
transparency of the systematic reviews conducted.
Post-operative pain after third molar surgery has become a frequently used model in the
studies of acute pain clinical trials. This is because third molar surgery is one of the commonest
procedure with sufficient numbers of patients to make studies relatively easy to perform [32].
It is also a sensitive method for demonstrating the efficacy of oral analgesic agents [19]. It is be-
cause the patient sample in dental pain model is homogenous in pain stimulus, and the post-
operative pain is frequently moderate or severe in intensity. Moreover, absence of multiple sur-
gical complication factors comparing to other major surgical procedures, trauma, or other pain
stimuli reduced to variables of the surgical procedure and outcome. In addition, third molar
surgical procedures can be easily categorized, and the obtained data in dental pain model can
substantiate the assay sensitivity of the clinical trials, and therefore it is useful in predicting the
general analgesic efficacy of NSAIDs [33, 34].
Fig 3. Forest plot according to TOTPAR.
doi:10.1371/journal.pone.0127611.g003
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Pooling of data in a systematic review were occasionally criticized to be “mixing apples and
oranges”, especially if there were obvious heterogeneity of the included studies. In this study,
the heterogeneity of the included studies in the Final Review has been tested to be less than
moderate (I2 = 0.0%), which enabled a representable meta-analysis to be performed.
The measurement of analgesic efficacy is usually performed by comparing patient’s subjec-
tive evaluation of pain before and after administration of the analgesics [35]. For a long time,
SPID and TOTPAR are the most commonly used methods to measure the efficacy of an anal-
gesic and were well validated [36–38]. They were used in the research context for comparisons
between the efficacies of different analgesics [39], and now routinely used in analgesic studies
[40–42]. In this systematic review, formulae of adjusted SPID and adjusted TOTPAR were de-
veloped by correction of the placebo effect of the respective studies of the analgesics. This may
allow direct cross-studies comparison of the analgesic combination efficacies and to reduce the
heterogeneity of the placebo effects in different studies.
Analgesic combinations have been proved to be more effective in pain control when com-
pared to single drug [43, 44]. The concurrent use of ibuprofen and paracetamol was the most
widely studied analgesic combination. It was shown in a Cochrane Review that 400mg ibupro-
fen / 1000mg paracetamol combination has superior analgesic effect when compared to ibu-
profen or paracetamol alone or the combination of the two of lower dosage [44]. However,
there were no other meta-analysis in the literature comparing the effectiveness and side effects
of different analgesic combinations.
This systematic review andmeta-analysis of analgesic combinations reported the objective an-
algesic efficacy and the adverse effects of various analgesic combinations studied in the literature.
One of the key findings of this study was ibuprofen 400mg + oxycodone HCL 5mg was found to
have the most effective analgesic effects in acute dental pain as measured by the objective efficacy
measurements of SPID6 and TOTPAR6. It was reported in the literature that ibuprofen 400mg
have a stronger analgesic efficacy than acetaminophen 1g [45, 46]. Post-operative inflammation
may magnify the process of acute pain signals which potentially lead to greater pain nociception
[47–50]. The anti-inflammatory action may therefore provide a higher analgesic efficacy. More-
over, oxycodone HCL is a stronger opioid when compared to codeine phosphate and hydroco-
done bitartrate. According the equianalgesia chart [51, 52], the analgesic potency of oxycodone
HCL is around 1.5–2.0 times stronger than hydrocodone bitartrate and 15–20 times stronger
than codeine phosphate. The combination of the two analgesics therefore was found to be superi-
or in terms of analgesic efficacy when compared to the other combinations.
Acetaminophen and codeine phosphate combination is a common analgesic combination
in clinical practice. Acetaminophen mechanism of action is not fully understood [3]. It was
suggested that the mechanism of acetaminophen may be related to inhibition of the nitric
oxide synthase [51], reduction of spinal prostaglandin E2 release [53], or reversal of the hyper-
algesia induced by N-methyl-D-aspartate (NMDA) [54, 55]. The side-effects of acetaminophen
are minimal. Unlike NSAIDs, acetaminophen is not likely to cause gastrointestinal irritation.
The prevalence of allergic reaction to acetaminophen is rarer when compared to the NSAIDs
counterpart. We noted the efficacy of acetaminophen 600mg + codeine phosphate 60mg was
doubled when compared to acetaminophen 300mg + codeine phosphate 30mg. We therefore
concluded for post-operative pain control after third molar surgery, a higher dosage of acet-
aminophen and codeine phosphate combination would be better in terms of analgesic efficacy.
However, it was also noted the raised dosage of codeine phosphate was related to an elevated
prevalence of drowsiness, which might not favorable especially to drivers or machine operators.
Taking all these factors into considerations, we recommend the combination of acetaminophen
600mg and codeine phosphate 60mg is effective for post-operative pain after third molar sur-
gery, and may be useful when the patient is allergic to NSAIDs.
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We noted most of the adverse effects of the combined analgesics from the included studies
were mostly contributed by centrally acting analgesic i.e. codeine phosphate, hydrocodone bi-
tartrate or oxycodone HCL. Their common side effects include drowsiness, dizziness, headache
and nausea and vomiting [56, 57]. Other possible adverse effects of opioids described in litera-
ture e.g. itching, dry mouth, flashes, sweating and chills were also reported in our study but in a
low prevalence [3, 58]. Severe adverse reactions of opioids in patients including tolerance, de-
pendence, confusion, hallucinations, delirium, hypothermia, bradycardia/tachycardia, ortho-
static hypotension and urinary retention were not found in our study [56, 57]. We believed
those uncommon adverse effects were more likely found in prolonged use of opioids in chronic
pain patients [59–61]. It was therefore very unlikely that a short-course use of analgesic for
acute dental post-operative pain would lead to these major adverse effects or severe complica-
tions. Clinicians have an important role to prescribe appropriate dosing such that patients
could gain the analgesic effects with the least adverse effects. Under suitable dosage, central act-
ing analgesic could be an effective and safe medication for the treatment of acute dental post-
operative pain.
One of the randomized clinical trials included in the final review compared 3 different dos-
ages of the combination of ibuprofen and caffeine. Caffeine is the central-nervous-system stim-
ulant which is an antagonist of adenosine receptors in the brain [62]. High dose of caffeine
may cause tolerance, insomnia, hallucination, reduced control of fine motor movements [52,
63–65]. We reported the adverse effects of the combinations of ibuprofen and caffeine was
minimal when compared to other combinations containing opioids. We also found the analge-
sic efficacies of ibuprofen 200mg with caffeine 100mg or 200mg were similar, with both much
superior than with caffeine 50mg. We presumed that the caffeine ceiling dose may be approxi-
mately at around 100mg and the combination of ibuprofen 200mg with caffeine 200mg might
not have an extra benefit in its analgesic effect.
The limitations of this systematic review and meta-analysis included the possibilities of re-
porting bias. Some pharmacological studies were sponsored by pharmaceutical companies,
which might only report favourable outcomes if a drug combination was shown to be superior.
Furthermore, our group did not request centers and companies to report if they had unpub-
lished data on this topic, which might not find all related studies or data about the clinical ques-
tion we defined.
In this study, the commonly reported adverse effects of NSAIDs (e.g. dyspepsia, gastric ul-
ceration/bleeding, diarrhea) were not found in the drug combinations. Non-selective NSAIDs
inhibit both cyclooxygenases (COX): COX-1 and COX-2 which reduce the levels of protective
prostaglandins, leading to increase in gastric acid secretion and diminish bicarbonate secretion
and mucus secretion [66, 67]. The included studies reported the use of analgesic combinations
containing NSAIDs only in a very short course for the acute dental pain. The dosages and the
duration of taking NSAIDs might not be sufficient to induce an obvious adverse effect in most
patients. The introduction of COX-2 selective inhibitors was reported to have a strong analge-
sic effect with less adverse effect on the gastrointestinal tract when compared to the non-selec-
tive NSAIDs. Stichtenoth DO and Frölich JC have suggested that selective COX-2 inhibitors
have significantly less gastric events and no effects on platelet aggregation [68]. However, a
COX 2 selective inhibitor was found to increase cardiovascular risks and was withdrawn from
the market [69, 70]. There are several COX-2 selective inhibitors still in the market and are
found to be safe to use. In this study, there was no well conducted RCT on the efficacy and safe-
ty of analgesic combinations with a COX-2 selective inhibitor included in the final review. We
therefore recommend future research to investigate the efficacy and side effects on the combi-
nation of COX-2 to another group of analgesic, which may potentially be a good analgesic
choice for post-operative pain after third molar surgery.
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Conclusion
This systematic review and meta-analysis of randomized clinical trials has presented the effica-
cy and adverse effects of the various analgesic combinations for acute post-operative dental
pain control. We have identified ibuprofen 400mg with oxycodone 5mg was more effective
when compared to the other 16 combinations. Nausea was the most common adverse effects in
an analgesic combination containing an opioid. Ibuprofen 200mg with caffeine 100mg or
200mg has a reasonable analgesic effect with fewer side effects when compared to the other
analgesic combinations.
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